An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
ORPEA'S RESPONSE TO THE PUBLIC STATEMENT FROM NEXTSTONE CAPITAL AND MAT IMMO BEAUNE
Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Negative)
Tags
Rhea-AI Summary
ORPEA has addressed misleading statements from shareholders Nextstone Capital and Mat Immo Beaune, who together own less than 3% of shares. The company asserts its commitment to its transformation plan, set to be presented on November 15. ORPEA highlights ongoing discussions with real estate investors regarding asset disposals, which have faced challenges due to macroeconomic conditions. The company's intent to convene a shareholders' meeting is criticized as lacking corporate interest. ORPEA emphasizes its dedication to transparency and the company’s long-term sustainability.
Positive
ORPEA plans to present a transformation plan on November 15 to ensure sustainability and future development.
The company is engaged in discussions for asset disposals despite current macroeconomic challenges.
Negative
The two minority shareholders' criticisms may undermine ORPEA's strategic plans.
Asset disposal negotiations have largely been unsuccessful due to the deteriorating macroeconomic context.
ORPEA (Paris:ORP) has become aware, simultaneously with the market, of the statement published by Nextstone Capital and Mat Immo Beaune, two shareholders claiming to be acting in concert and together representing less than 3% of the share capital and voting rights.
Given the numerous misleading statements contained in this letter, ORPEA intends to restore the accuracy and reality of the facts for the market and notes that this statement is made in disregard of the main market stance on shareholder activism.
The Company notes that even before the presentation of ORPEA's transformation plan on 15 November, these two minority shareholders are publicly criticizing the Group's strategic orientations in the form of allegations, in support of a thesis that only aims at dismantling the Group.
ORPEA wishes to emphasize that it has put all the necessary resources to complete the operations anticipated by the conciliation protocol (protocole de conciliation) dated June 2022. Besides, the Company was in advanced discussions with real estate investors on asset disposals even before the approval (homologation) of this protocol. These negotiations have been actively pursued but have not, for most of them, been successful to date due to the deterioration of the macro-economic context and the Group's particular situation.
Moreover, the request to convene a shareholders’ general meeting, more importantly without any provided agenda, is not driven by ORPEA's corporate interest (intérêt social).
Finally, the Company reiterates that it has always disclosed the sensitive information it holds and reaffirms that it acts solely in the corporate interest of the firm and its stakeholders.
The Company reserves all rights of actions with regard to the false, serious and/or defamatory allegations contained in the letter of these two minority shareholders.
As already announced, ORPEA will present its transformation plan on 15 November, the aim of which is to ensure its sustainability and future development.
About ORPEA
ORPEA is a leading global player, expert in the care of all types of frailty. The Group operates in 22 countries and covers three core businesses: care for the elderly (nursing homes, assisted living, home care), post-acute and rehabilitation care and mental health care (specialized clinics). It has more than 71,000 employees and welcomes more than 255,000 patients and residents each year.